Importantly, an antibody blockade of PD-L1 decreased cancer cell proliferation and enhanced sensitivity to IFNβ in murine and human melanoma cancer cells [97], a mechanism later confirmed in other tumor types [125,126]. The gene discussed is CD274; the disease is cancer.